InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by LAWLOR AUGUSTINE, Director. Director active across 3 companies, notably Catalyst Biosciences, INC.. In total, 13 disclosures have been recorded. Activity tracked since 1 July 2021. The latest transaction was disclosed on 13 November 2024 (X). Regulator: SEC (Form 4). All data is free.
Declarations13 total
22,500 sharesCommon StockSEC:0001104659-25-030808:0
2,136 shares@ US$2.82100.0% of flowCommon StockSEC:0001104659-24-119793:0
5,000 sharesCommon StockSEC:0001104659-24-008418:0
24.573 sharesSeries Y Preferred StockSEC:0001140361-23-042365:0
5,022 shares@ US$20.00100.0% of flowCommon StockSEC:0001062993-23-009600:0
1,222 shares0Common StockSEC:0000914190-21-000411
1,222 shares0Common StockSEC:0000914190-21-000411:0
5,839 shares0Common StockSEC:0001209191-21-059429:0
5,839 shares0Common StockSEC:0001209191-21-059429
1,710 shares0Common StockSEC:0000914190-21-000245:0
1,710 shares0Common StockSEC:0000914190-21-000245
5,542 shares0Common StockSEC:0001209191-21-044690
5,542 shares0Common StockSEC:0001209191-21-044690:0
13 of 13 declarations
About LAWLOR AUGUSTINE
Augustine Lawlor is a Board Member of Catalyst Biosciences, Inc. and Cardiovascular Systems Inc. In this role, he provides strategic expertise and valuable insights to the board of directors. His experience in the biotechnology and medical device sectors helps guide strategic decisions and support the mission of these companies.
